Imunon, Inc. — Director's Dealing 2020

Feb 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2020-02-25

Reporting Person: Tardugno Michael H (Director, Chairman, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-25	Celsion Corporation Common Stock	A	155000	$1.16	Acquired	187700	Direct

Footnotes

F1: The Filer received Celsion Common Stock as part of their incentive compensation.